Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1
(1989): Decrease in respiratory quotient during exercise following L-carnitine supplementation
Effect: Anti-Dark Spot Anti-aging, spot-free, brighter, healthier, more radiant skin, glutathione & vitamin C, E and carrot oil Glutathione Skin Lightening Body Lotion Lait de Corps claircissant la Glutathione Potent Lightening Body Lotion with collagen, AHA and vitamin C Anti-Dark Spot Anti-aging Body lotion with glutathione and fruit extract
Researchers have found diseases including cardiovascular disease, non-alcoholic fatty liver disease, diabetic chronic kidney disease, osteoarthritis, autoimmune disease, alcohol use disorder and more could be positively impacted by GLP-1RA therapy
First, GI adverse effects were numerically more common with CagriSema (58Percentage) compared with semaglutide (32Percentage) or cagrilintide (32Percentage) [10]
